KUALA LUMPUR, Nov 5 (Bernama) -- Bursa Malaysia closed higher, buoyed by Bank Negara Malaysia’s (BNM) decision to maintain the Overnight Policy Rate (OPR) at 2.75 per cent, alongside positive cues from Wall Street. At 5 pm, the FTSE Bursa Malaysia KLCI (FBM KLCI) rose 19.30 points, or 1.19 per cent, to 1,635.86 from Wednesday’s close of 1,616.56. The benchmark index opened 6.72 points higher at 1,623.28, and fluctuated between an intraday high of 1,642.44 and a low of 1,622.62 during the trading session. However, market breadth was negative, with losers outnumbering gainers 723 to 497, while 466 counters were unchanged, 1,075 untraded and 10 suspended. Turnover rose to 3.74 billion units valued at RM3.61 billion compared with yesterday’s 2.81 billion units valued at RM2.57 billion.
Not all rallies scream with hype. Some, like Harbin Pharmaceutical Group , climb quietly — backed not by noise, but by solid fundamentals . +11% in the past month. 57% earnings growth over five years. ROE of 11% vs. industry average of 7.1%. These aren’t meme metrics — these are the hallmarks of a business executing well behind the scenes. What’s Driving It? Efficient capital use : For every ¥1 in equity, Harbin Pharma returns ¥0.11 in profit. Reinvesting 100% of its earnings. No dividends. Just pure business reinvestment. Outpaced its industry : While peers averaged 6.2% net income growth, Harbin clocked in 57%. That’s the kind of compounding investors dream of — and rarely find without digging. But Here’s the Twist… Analysts expect earnings growth to slow down . Whether that’s a sector-wide sentiment shift or a real red flag depends on how well management can continue allocating capital effectively. Stock Picker’s Take: This is a “sleep well a...